Stalevo (Carbidopa/Levodopa/Entacapone) — Patient-Friendly Guide

Stalevo is a medicine used for the treatment of Parkinson’s disease. It combines medicines that help improve symptoms by increasing and extending the effect of levodopa in the brain. In the UK, Stalevo is prescribed for people who experience wearing-off (when benefits of levodopa become less reliable before the next dose).

This guide explains how Stalevo works, how it is typically taken, key safety points, common interactions (including alcohol), and practical tips to help you use it effectively. Always follow the instructions given by your healthcare professional and read the leaflet provided with your medicine.

Basic product information

How Stalevo works (mechanism of action)

Parkinson’s disease can reduce dopamine levels in the brain. Levodopa is a precursor that the body can convert to dopamine, helping improve movement-related symptoms. Stalevo contains three components, each with an important role:

• Levodopa: enters the brain and is converted to dopamine, helping improve stiffness, slowness (bradykinesia), and mobility.
• Carbidopa: helps prevent levodopa being converted to dopamine in the rest of the body. This increases the amount reaching the brain and reduces some side effects such as nausea.
• Entacapone: inhibits catechol-O-methyltransferase (COMT), an enzyme that breaks down levodopa. By slowing this breakdown, entacapone helps levodopa work for longer and can reduce “off” periods.

The overall result is more stable benefit from levodopa throughout the day, which is especially helpful for people who experience wearing-off between doses.

Pharmacokinetics — what the body does to the medicine

“Pharmacokinetics” describes how the body absorbs, distributes, metabolises, and clears a medicine. While individual responses vary, the key points for Stalevo generally include:

• Absorption: Levodopa and entacapone are absorbed from the tablet into the bloodstream. Absorption can be influenced by food timing (see “Food interactions” below).
• Peak effect: After taking a dose, medication levels rise and usually produce symptom improvement over the following period. The timing and duration depend on dose strength, individual metabolism, and meal timing.
• Entacapone effect: Entacapone’s role is to reduce levodopa breakdown, tending to extend the time levodopa remains active.
• Metabolism and elimination: Carbidopa, levodopa, and entacapone are processed by the body through metabolic pathways and are removed mainly via urine and bile (exact proportions can vary by component and patient factors).

Because Stalevo is used to tailor daily symptom control, your prescriber may adjust the number of doses and dose strength to achieve the best balance between benefit and side effects.

What Stalevo is used for (indications)

In the UK, Stalevo is used in adults with Parkinson’s disease to:

• Improve Parkinson’s symptoms by increasing the availability and duration of levodopa in the body and brain.
• Reduce wearing-off (“end-of-dose” failure), where symptoms return before the next regular levodopa dose.
• Optimise combination therapy when entacapone is already part of treatment or when adjustment to levodopa/entacapone schedules is needed.

Stalevo is generally considered when standard levodopa therapy is not providing consistent benefit across the day.

Timing and how to take Stalevo

Taking Stalevo at the right time helps maintain steadier symptom control. Typical guidance includes:

• Follow your dosing schedule exactly as advised.
• Take with regular timing (often several times daily). Doses are commonly spaced so that they cover your day-time “on” periods and reduce “off” periods.
• Consistency matters: aim to take each dose at similar times each day. If you notice dose timing affects your mobility, tell your healthcare professional.
• Do not change dose strength without advice. Stalevo comes in different strengths; using the wrong strength can lead to side effects or reduced benefit.

Missed dose: If you miss a dose, take it when you remember unless it is close to the next dose. Do not take a double dose to make up for a missed tablet. If you are unsure, ask a pharmacist or healthcare professional for advice.

Dosing — general principles

The appropriate dose of Stalevo depends on your current Parkinson’s regimen, symptom control, and tolerance to side effects. Doses are individualised. In general, prescribers may:

• Start at a dose strength similar to the levodopa regimen you already take.
• Adjust gradually based on response and side effects.
• Use the levodopa “per dose” concept: changing tablet strength changes the levodopa dose per administration.

Key safety dosing point: Keep a note of what strength you take and how often. If you or a carer assists with medicines, it can help to use a medication organiser and a written schedule.

If you have kidney problems or liver impairment, your prescriber may require closer monitoring and possible dose adjustments.

Food interactions — what to watch

Food can influence the absorption and timing of levodopa. This may affect when your next dose begins working. Practical tips include:

• Protein-rich meals: high-protein foods can compete with amino acids for transport into the brain. Some people notice that taking levodopa close to protein-heavy meals reduces effectiveness. If this applies to you, your healthcare professional may advise adjusting meal timing or overall dietary strategy.
• Consistency is helpful: if you usually eat at similar times, try to keep levodopa timing consistent relative to meals.
• Timing adjustments: if you experience delayed “on” periods after meals, speak to your clinician about the timing of your doses.

What about swallowing and nausea? Carbidopa helps reduce nausea, but some people still experience it. Taking a dose as advised (with water, and not crushing unless instructed) may help. Do not change tablet form unless your pharmacist confirms it is appropriate.

Alcohol and medicine interactions

Alcohol can worsen dizziness, drowsiness, and balance problems. When combined with medicines used in Parkinson’s disease, alcohol may increase the risk of:

• falls or feeling faint
• sleepiness or impaired reaction time
• orthostatic hypotension (a drop in blood pressure when standing)

There is no universal “safe amount” for everyone. If you drink alcohol, it may be wise to discuss safe limits with your healthcare professional. In addition, alcohol can aggravate nausea in some people.

Other medicine interactions (important)

Stalevo may interact with a range of medicines. Always tell your pharmacist or healthcare professional about all medicines you take, including over-the-counter products and herbal remedies. Common categories that may be relevant include:

• Antipsychotics (some can worsen Parkinson’s symptoms).
• Antidepressants, especially MAO inhibitors (and certain combinations) — these require careful consideration.
• Iron preparations (can interfere with levodopa absorption in some cases).
• Antiemetics and medicines affecting nausea (your clinician may choose options that are compatible).
• Blood pressure medicines: levodopa can sometimes lower blood pressure; combined effects may occur.

This is not an exhaustive list. For personalised advice, consult your pharmacist, especially before starting any new medicine.

Safety profile — side effects and precautions

Like all medicines, Stalevo can cause side effects. Not everyone experiences them. Many side effects can be dose-related and may improve with careful adjustment. Seek medical advice promptly if you experience severe, worsening, or unexpected symptoms.

Common side effects

• Nausea or indigestion
• Dizziness or light-headedness
• Dry mouth (in some people)
• Abnormal involuntary movements (dyskinesia), especially at higher doses or with “wearing-off” improvement
• Diarrhoea (entacapone may contribute)
• Dark urine (can be caused by entacapone; usually harmless but report persistent changes)
• Headache

Less common but important effects

• Low blood pressure on standing (orthostatic hypotension), sometimes causing fainting.
• Sleep problems including insomnia or sudden sleepiness in some cases.
• Hallucinations, confusion, or behavioural changes (more likely in vulnerable individuals).
• Allergic reactions (e.g., rash, swelling, breathing difficulty). Seek urgent help if you have signs of anaphylaxis or severe allergy.

Severe or urgent warning symptoms

Contact urgent medical services or seek emergency help if you experience:

• chest pain, severe shortness of breath, or signs of severe allergic reaction
• collapse/fainting repeatedly
• a sudden high fever, severe muscle stiffness, and confusion (rare but serious)
• new severe confusion, agitation, or inability to stay awake

When extra monitoring is needed

Your clinician may monitor you more closely if you have conditions such as:

• liver disease (entacapone is handled by the body; caution may be needed)
• ongoing stomach or bowel issues
• a history of psychosis or significant hallucinations
• breathing problems or significant falls risk

Practical use tips (helpful day-to-day guidance)

• Use a schedule you can trust: consider a pill organiser, alarm reminders, or a written timetable (especially if multiple doses are used each day).
• Keep medication consistent with meals: if meals affect your “on/off” periods, aim for steady meal timing and discuss changes with your prescriber.
• Track response: some people find it helpful to note when tablets are taken and when mobility changes occur (e.g., “on”, “off”, dizziness, diarrhoea). This can assist medication adjustments.
• Stay hydrated: if you experience diarrhoea or vomiting, hydration is important. If diarrhoea persists or is severe, seek advice.
• Driving and operating machinery: Stalevo can cause dizziness or sleepiness in some people. Do not drive or operate machinery if you feel drowsy or your reaction time is affected. UK guidance regarding fitness to drive may apply—discuss concerns with your clinician.
• Watch for behavioural changes: rare impulse-control problems can occur with dopamine-related therapy. If you or family notice changes such as gambling urges, compulsive shopping, or unusual sexual behaviour, report it promptly.

Alternative treatment options

Parkinson’s disease treatment is tailored to the individual. Alternatives depend on your symptoms and what you are currently using. Options your clinician may consider include:

• Levodopa/carbidopa tablets without entacapone (for those where wearing-off may not be prominent).
• Entacapone as separate tablets added to existing levodopa/carbidopa therapy (when appropriate).
• Other COMT inhibitors (e.g., tolcapone in certain circumstances, under closer supervision) or other adjunct options depending on availability and suitability.
• Other Parkinson’s medicines such as dopamine agonists, MAO-B inhibitors, amantadine, or anticholinergic medicines (chosen based on age, symptoms, and side-effect risks).
• Advanced therapies in selected patients (e.g., device-aided delivery, specialist surgical approaches) when symptoms become difficult to manage.

If you are considering switching from Stalevo, do not stop suddenly. Discuss changes with your healthcare professional to avoid worsening symptoms or complications.

UK market and legal context (general information)

In the UK, medicines such as Stalevo are regulated under the Human Medicines Regulations. Supply is governed by UK medicines legislation and pharmacy standards. Medicines may require appropriate prescribing and follow local rules for supply, labelling, and patient information.

Online pharmacies in the UK should be registered and follow applicable legal and regulatory requirements, including providing clear product information, safety guidance, and secure ordering. Always ensure you use a reputable, compliant service.

Recent guidance and safety updates

Parkinson’s disease treatment guidance and safety updates can change over time based on evidence and pharmacovigilance. In practice, clinicians often consider:

• monitoring for neuropsychiatric symptoms (hallucinations, confusion)
• dose adjustments to reduce wearing-off while limiting dyskinesia
• careful interaction checks when adding antidepressants, antipsychotics, or other high-risk medicines
• awareness of diarrhoea and dehydration risks with entacapone-containing regimens

For the most current information, your healthcare team will reference the latest NHS and professional guidance and the up-to-date patient information leaflet.

Delivery and availability in the UK

Availability can vary by strength and tablet count. When you order online, the medicine may be dispatched from a UK-registered supply chain. Delivery time depends on stock status and the delivery service chosen at checkout.

To help avoid delays:

• Double-check the exact strength and formulation you need.
• Ensure delivery details are correct (postcode, address, and access information).
• Plan ahead for repeat orders so you do not run out.

If you have urgent needs or notice stock shortages, contact customer support or a pharmacist. Some strengths may be temporarily unavailable.

FAQ — Stalevo (Carbidopa/Levodopa/Entacapone)

1) What is Stalevo used for?

Stalevo is used for Parkinson’s disease to improve symptoms and help reduce wearing-off between doses. It combines levodopa (to increase dopamine in the brain), carbidopa (to reduce breakdown outside the brain), and entacapone (to prolong levodopa’s effect).

2) When should I take Stalevo?

Take Stalevo exactly as advised by your healthcare professional. Many people take it several times a day, timed to manage “on” and “off” periods. Keeping consistent timing relative to meals can help.

3) Can I take Stalevo with food?

Yes, but food—especially protein-rich meals—may influence how quickly levodopa works for some people. Aim for consistency. If you notice doses seem less effective around meals, discuss timing or diet strategies with your clinician.

4) Will Stalevo interact with alcohol?

Alcohol can increase dizziness, drowsiness, and the risk of falls. It may worsen nausea and impair reaction time. If you drink alcohol, discuss safe limits with your healthcare team.

5) What side effects should I watch for?

Common effects include nausea, dizziness, diarrhoea, dyskinesia (involuntary movements), and dark urine. Seek urgent advice if you develop severe allergic reactions, fainting, significant confusion, or other serious symptoms.

6) Is dark urine normal?

Dark urine can occur with entacapone and is often harmless. However, if you notice persistent severe changes or you feel unwell, contact a pharmacist or clinician for advice.

7) What if I miss a dose?

Take it when you remember unless it is almost time for your next dose. Do not take a double dose. If unsure, ask your pharmacist.

8) Can I stop Stalevo suddenly?

Do not stop suddenly unless your healthcare professional tells you to. Sudden changes can worsen Parkinson’s symptoms or cause complications. If stopping is considered, it should be discussed and planned.

9) Who should be extra careful with Stalevo?

People with liver problems, a history of hallucinations or psychosis, significant low blood pressure, or those at high risk of falls may need closer monitoring. Always review your full medical history with your prescriber and pharmacist.

10) Are there alternatives to Stalevo?

Yes. Alternatives may include levodopa/carbidopa alone, COMT inhibitors, and other Parkinson’s medicines. Choice depends on your symptoms, severity of wearing-off, and side-effect tolerance.

Important note: This page provides general information about Stalevo. It does not replace the patient information leaflet or advice from a qualified healthcare professional. If you have any questions about how to take Stalevo, side effects, or interactions with other medicines, speak to your pharmacist or healthcare team.